{"id":24766,"date":"2022-11-27T18:39:03","date_gmt":"2022-11-27T17:39:03","guid":{"rendered":"https:\/\/www.ltslohmann.com\/aktuelles\/micro-array-patches-hintergrund-und-fallstudie\/"},"modified":"2022-11-27T18:53:46","modified_gmt":"2022-11-27T17:53:46","slug":"micro-array-patches-hintergrund-und-fallstudie","status":"publish","type":"post","link":"https:\/\/www.ltslohmann.com\/de\/webcasts-de\/micro-array-patches-hintergrund-und-fallstudie\/","title":{"rendered":"Micro Array Patches &#8211; Hintergrund und Fallstudie"},"content":{"rendered":"\n<p>Erhalten Sie einen Einblick in die Entwicklung eines Interferon-\u00df-haltigen MAP (Micro Array patches) und die Ergebnisse von zwei Prototypen in einer pr\u00e4klinischen Studie. Unsere zweite Fallstudie wird \u00fcber vorl\u00e4ufige Ergebnisse einer klinischen Phase-I-Studie mit unserem Hepatitis-B-Antigen-haltigen MAP informieren. Sie wird die Induktion einer st\u00e4rkeren Immunantwort im Vergleich zur klassischen Injektionsimpfung zeigen.<\/p>\n\n<p><strong>Sprache:<\/strong> EN<\/p>\n\n<p><strong>Pr\u00e4sentiert von:<\/strong><\/p>\n\n<p>Frank Theobald<br\/>Markus Winterberg<\/p>\n\n<div class=\"fusion-button-wrapper\"><a class=\"fusion-button button-flat fusion-button-default-size button-custom fusion-button-default button-1 fusion-button-default-span fusion-button-default-type\" style=\"--button_accent_color:#525252;--button_accent_hover_color:#ffffff;--button_border_hover_color:#ffffff;--button_gradient_top_color:rgba(255,255,255,0);--button_gradient_bottom_color:rgba(255,255,255,0);--button_gradient_top_color_hover:rgba(255,255,255,0);--button_gradient_bottom_color_hover:rgba(255,255,255,0);\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/youtu.be\/rgo4CUCqv4c\"><i class=\"ltsiconlts-icon-patch awb-button__icon awb-button__icon--default button-icon-left\" aria-hidden=\"true\"><\/i><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Auf Youtube ansehen<\/span><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Erhalten Sie einen Einblick in die Entwicklung eines Interferon-\u00df-haltigen MAP (Micro Array patches) und die Ergebnisse von zwei Prototypen in einer pr\u00e4klinischen Studie.<\/p>\n","protected":false},"author":3,"featured_media":24767,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[],"class_list":["post-24766","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webcasts-de"],"_links":{"self":[{"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/posts\/24766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/comments?post=24766"}],"version-history":[{"count":1,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/posts\/24766\/revisions"}],"predecessor-version":[{"id":24768,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/posts\/24766\/revisions\/24768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/media\/24767"}],"wp:attachment":[{"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/media?parent=24766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/categories?post=24766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ltslohmann.com\/de\/wp-json\/wp\/v2\/tags?post=24766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}